Trials / Unknown
UnknownNCT06139367
A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
A Randomized, Open, Parallel, Single Center Phase I Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of TQB3454 Tablets in Healthy Adult Subjects.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open, parallel, single center phase I clinical trial to evaluate the impact of food on the pharmacokinetics of TQB3454 tablets in healthy adult subjects. The aim is to evaluate the impact of food on the pharmacokinetics as well as the safety after single dose of TQB3454 tablets taken orally by Chinese healthy adult subjects, with pharmacokinetic indicators as the primary endpoint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQB3454 tablets | TQB3454 is a Isocitrate dehydrogenase 1 (IDH1) mutation inhibitor. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-11-18
- Last updated
- 2023-11-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06139367. Inclusion in this directory is not an endorsement.